Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

62.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 119.60p
  • 52 Week Low: 35.30p
  • Currency: UK Pounds
  • Shares Issued: 540.14m
  • Volume: 417,457
  • Market Cap: £334.89m
  • RiskGrade: 119

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 5.21 4.28p 12.4 n/a -33% 1.78p 3.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 189.57 43.33 5.48p 11.3 0.4 +28% 1.84p 0.0%
31-Dec-24 211.70 50.69 6.66p 9.3 0.4 +22% 1.98p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 14.76 12.38 15.57 0.93

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 62.00p
Change Today 0.50p
% Change 0.81 %
52 Week High 119.60p
52 Week Low 35.30p
Volume 417,457
Shares Issued 540.14m
Market Cap £334.89m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.97% above the market average38.97% above the market average38.97% above the market average38.97% above the market average38.97% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Price Trend
12.72% below the market average12.72% below the market average12.72% below the market average12.72% below the market average12.72% below the market average
8.20% above the sector average8.20% above the sector average8.20% above the sector average8.20% above the sector average8.20% above the sector average
Income
29.95% below the market average29.95% below the market average29.95% below the market average29.95% below the market average29.95% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Growth
90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 01-Jun-2023

Time Volume / Share Price
16:37 10,000 @ 62.00p
16:35 61,810 @ 62.00p
16:35 22 @ 62.00p
16:35 120 @ 62.00p
16:35 200 @ 62.00p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Jo Le Couilliard

Top of Page